Skip to main content

OMCL

Stock
Health Care
Health Information Services

Performance overview

OMCL Price
Price Chart

Forward-looking statistics

Beta
1.22
Risk
57.55%

Detailed forecast

[disclaimer]

Individual forecast components (weighted-sum)

Company Profile

Omnicell Inc provides automation and business analytics software for healthcare providers. It helps its customers to define and deliver cost-effective medication management that is designed to equip and empower pharmacists and nurses to focus on patient care rather than administrative tasks, and to drive improved clinical, operational, and financial outcomes across all care settings. Omnicell generates the vast majority of its revenue in the United States.

Company info

SectorHealth Care
IndustryHealth Information Services
Employees3K
Market cap$1.4B

Fundamentals

Enterprise value$1.4B
Revenue$1.1B
Revenue per employee
Profit margin1.86%
Debt to equity30.69

Security info

ExchangeNASDAQ
Type of shareCommon Stock
Earnings per share (EPS)$0.46
Dividend per share
Revenue per share$24.55
Avg trading volume (30 day)$15M
Avg trading volume (10 day)$13M
Put-call ratio

Macro factor sensitivity

Growth+5.4
Credit+0.9
Liquidity-3.2
Inflation+3.5
Commodities+2.8
Interest Rates-1.0

Valuation

Dividend yield0.00%
PEG Ratio16.58
Price to sales1.23
P/E Ratio16.58
Enterprise Value to Revenue1.21
Price to book1.11

Upcoming events

Next earnings dayMay 6, 2025
Next dividend day
Ex. dividend day

News

Is it Apt to Retain Omnicell Stock in Your Portfolio Now?

OMCL stays on investors' radar due to its strong 2025 growth targets with automation and tech services, but faces margin risks from macro and competitive headwinds.

Zacks Investment Research (June 6, 2025)

Unlock Personalized Financial Tools

All our core financial tools are completely free. Create an account to save your research, get personalized recommendations, and enjoy unlimited access.

Save research to draft portfolios
Get personalized recommendations
Access unlimited tool usage
Sign up for free